Theranos Offensive: Advisory Board Announced, Claims They Never Intended To Host Clinton FundraiserMark Melin
Controversial blood testing organization Theranos is going on the offensive in the wake of an apparent second regulatory rebuke and finding itself at the center of slight controversy involving the presidential bid of Hillary Clinton.
The company announced the expansion of medical advisory board to address what a spokesperson said was its key problem: management and leadership oversight. Against this background the $9 billion medical start-up clarified its involvement in a recent fund raising event involving Elizabeth Homes and Chelsea Clinton.
Theranos . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible